Market Overview

15 Biggest Mid-Day Gainers For Wednesday

Share:
  • Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 64.1 percent to $1.87.
  • Uranium Resources, Inc. (NASDAQ: URRE) shares surged 58.3 percent to $3.56. Uranium Resources shares have dropped 60.94 percent over the past 52 weeks, while the S&P 500 index has gained 17.95 percent in the same period.
  • MYOS RENS Technology Inc (NASDAQ: MYOS) shares gained 42.3 percent to $1.85. MYOS RENS Technology shares have declined 26.55 percent over the past 52 weeks, while the S&P 500 index has gained 17.95 percent in the same period.
  • Derma Sciences Inc (NASDAQ: DSCI) shares jumped 39 percent to $6.95 after the company agreed to be acquired by Integra Lifesciences Holdings Corp (NASDAQ: IART) for $7.00 per share in cash.
  • Biocept Inc (NASDAQ: BIOC) shares surged 33.7 percent to $2.42 after climbing 77.45 percent on Tuesday.
  • E-compass Acquisition Corp. (NASDAQ: ECAC) shares rose 28 percent to $12.67 after the company announced plans to merge with NYM Holding, Inc.
  • Enphase Energy Inc (NASDAQ: ENPH) gained 19.5 percent to $1.35 after the company reported a $10 million strategic investment from T.J.Rodgers and John Doerr.
  • Kornit Digital Ltd (NASDAQ: KRNT) shares gained 15.4 percent to $16.10 after the company disclosed that it has signed an agreement with Amazon for digital printing technology to help Amazon expand on-demand production for garment decoration.
  • Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) shares jumped 10.9 percent to $2.24 after climbing 6.88 percent on Tuesday.
  • Merck & Co., Inc. (NYSE: MRK) gained 4.7 percent to $62.74 after the company disclosed that it has received the FDA acceptance of supplemental Biologics License Application for KEYTRUDA.
  • Keryx Biopharmaceuticals (NASDAQ: KERX) rose 4.4 percent to $6.47. Citigroup upgraded Keryx Biopharmaceuticals from Sell to Neutral.
  • Williams Partners LP (NYSE: WPZ) gained 3.6 percent to $40.01. Wells Fargo upgraded Williams Partners from Market Perform to Outperform.
  • Sangamo Therapeutics Inc (NASDAQ: SGMO) shares rose 3.4 percent to $3.78 after the company disclosed that it has received Orphan Drug designation from the FDA for SB-318.
  • TG Therapeutics Inc (NASDAQ: TGTX) shares gained 2.5 percent to $5.12 after the company disclosed positive MS study data.
  • Achaogen Inc (NASDAQ: AKAO) shares rose 2 percent to $15.76 after Baker Bros Advisors reported a 13.1 percent stake in the company.

Latest Ratings for DXTR

DateFirmActionFromTo
Aug 2017Ladenburg ThalmannInitiates Coverage OnBuy
Jul 2017WedbushMaintainsOutperform

View More Analyst Ratings for DXTR
View the Latest Analyst Ratings

Posted-In: Mid-Day GainersNews Intraday Update Markets Analyst Ratings Movers

 

Related Articles (ARWR + AKAO)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
PEPMorgan StanleyReiterates137.0
AZRXH.C. WainwrightMaintains7.0
PEPMacquarieMaintains138.0
POLBuckinghamMaintains36.0
BKBuckinghamMaintains53.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

This Fund Will Try To Prevent Skynet From Actually Happening

AUD/USD Gains Erode